Business Description
NGeneBio Co Ltd
ISIN : KR7354200008
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.31 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | -1.23 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.03 | |||||
Beneish M-Score | -6.87 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.6 | |||||
3-Year EBITDA Growth Rate | 1.4 | |||||
3-Year EPS without NRI Growth Rate | -6.1 | |||||
3-Year FCF Growth Rate | -5.3 | |||||
3-Year Book Growth Rate | -28 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.22 | |||||
9-Day RSI | 18.9 | |||||
14-Day RSI | 26.12 | |||||
6-1 Month Momentum % | -17.79 | |||||
12-1 Month Momentum % | -41.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.86 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 196.38 | |||||
Days Sales Outstanding | 77.46 | |||||
Days Payable | 14.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | -4.15 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -6.09 | |||||
Operating Margin % | -354.13 | |||||
Net Margin % | -337.94 | |||||
FCF Margin % | -236.66 | |||||
ROE % | -73.85 | |||||
ROA % | -28.21 | |||||
ROIC % | -33.29 | |||||
ROC (Joel Greenblatt) % | -128.15 | |||||
ROCE % | -58.61 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 10.68 | |||||
PB Ratio | 3.15 | |||||
Price-to-Tangible-Book | 4.81 | |||||
EV-to-EBIT | -3.24 | |||||
EV-to-EBITDA | -3.67 | |||||
EV-to-Revenue | 9.76 | |||||
EV-to-FCF | -4.09 | |||||
Earnings Yield (Greenblatt) % | -30.88 | |||||
FCF Yield % | -21.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NGeneBio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 3,849.41 | ||
EPS (TTM) (â‚©) | -1018 | ||
Beta | 1.37 | ||
Volatility % | 40.3 | ||
14-Day RSI | 26.12 | ||
14-Day ATR (â‚©) | 278.486102 | ||
20-Day SMA (â‚©) | 3821.5 | ||
12-1 Month Momentum % | -41.6 | ||
52-Week Range (â‚©) | 3150 - 9800 | ||
Shares Outstanding (Mil) | 12.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NGeneBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NGeneBio Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
NGeneBio Co Ltd Frequently Asked Questions
What is NGeneBio Co Ltd(XKRX:354200)'s stock price today?
When is next earnings date of NGeneBio Co Ltd(XKRX:354200)?
Does NGeneBio Co Ltd(XKRX:354200) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |